Back to Ll-37 research
ll-37 antimicrobial peptide in vitro n preclinical 2026-04-03 PubMed

Antimicrobial Peptides LL-37, HNP-1, and Magainin-2 Use Distinct Mechanisms

Structural and mechanistic divergence in LL-37, HNP-1, and Magainin-2: An integrated computational and biophysical analysis.

Background

Antimicrobial peptides (AMPs) are crucial components of the innate immune system, acting as a first line of defense against pathogens. With the global rise of antibiotic resistance, there is an urgent need to develop novel antimicrobial strategies. Understanding the diverse ways AMPs interact with bacterial membranes is fundamental to this goal. This study meticulously investigates the structural and mechanistic differences among three prominent AMPs: LL-37, HNP-1, and Magainin-2.

Results

The study revealed significant structural and mechanistic divergence. LL-37 consistently adopted an alpha-helical conformation upon membrane binding, leading to rapid pore formation and causing 85% leakage in E. coli lipid vesicles within 30 minutes at a concentration of 5 µM. In contrast, HNP-1 maintained its characteristic beta-sheet structure, primarily disrupting membranes via a carpet-like mechanism, resulting in 60% leakage in S. aureus vesicles after 60 minutes at the same concentration. Magainin-2 exhibited a mixed alpha-helical/random coil structure, inducing membrane thinning and translocation, with an MIC of 2-4 µM against E. coli and 8-16 µM against S. aureus. Computational models further predicted distinct binding affinities and membrane insertion depths, with LL-37 showing a 2.5-fold higher affinity for anionic lipids compared to Magainin-2. > The study's most critical finding is that despite their shared antimicrobial function, LL-37, HNP-1, and Magainin-2 utilize fundamentally different membrane interaction strategies, with LL-37 demonstrating 2.3-fold faster membrane permeabilization kinetics than HNP-1 in Gram-negative bacterial models.

Why It Matters

This research provides crucial insights into the diverse mechanisms by which antimicrobial peptides exert their effects. Understanding these structural and mechanistic differences is paramount for the rational design of next-generation antimicrobial agents that can circumvent drug resistance and target specific pathogens more effectively. This foundational knowledge could accelerate the development of novel AMP-based therapeutics with tailored specificities and reduced off-target effects. Future work should focus on validating these mechanisms in complex biological systems, including in vivo animal models, and optimizing peptide sequences for enhanced clinical efficacy.


ll-37 antimicrobial peptide cathelicidin pore formation membrane thinning translocation dose mentioned
Source: pubmed:41376844 · Ingested 2026-04-03 · Digest: gemini-2.5-flash